Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Operating Income: 2019-2025

Historic Operating Income for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$41.8 million.

  • Benitec Biopharma's Operating Income fell 77.25% to -$9.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$41.8 million, marking a year-over-year decrease of 85.70%. This contributed to the annual value of -$41.8 million for FY2025, which is 85.70% down from last year.
  • As of FY2025, Benitec Biopharma's Operating Income stood at -$41.8 million, which was down 85.70% from -$22.5 million recorded in FY2024.
  • Benitec Biopharma's Operating Income's 5-year high stood at -$13.6 million during FY2021, with a 5-year trough of -$41.8 million in FY2025.
  • Moreover, its 3-year median value for Operating Income was -$22.5 million (2024), whereas its average is -$27.8 million.
  • Data for Benitec Biopharma's Operating Income shows a maximum YoY tumbled of 85.70% (in 2025) over the last 5 years.
  • Over the past 5 years, Benitec Biopharma's Operating Income (Yearly) stood at -$13.6 million in 2021, then crashed by 31.32% to -$17.9 million in 2022, then fell by 6.87% to -$19.1 million in 2023, then dropped by 17.87% to -$22.5 million in 2024, then slumped by 85.70% to -$41.8 million in 2025.